Menopur 75 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQV2A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $170,163
Award facts
- Contract value 100% obligated
- $170,163.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $170,163.09 firm fixed-price delivery order from the Defense Logistics Agency on January 22, 2026, for Menopur 75 Unit Vials. The award is not set-aside and represents a child contract under the parent entity Cencora, Inc. (doing business as AmerisourceBergen). Performance will be completed by January 23, 2026, with work performed at the contractor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Menopur is a hormone treatment medication used in fertility and reproductive health applications. This competitive award reflects AmerisourceBergen's established capability to meet federal medical procurement requirements and serves the Defense Health Agency and other government healthcare systems. The contract award demonstrates the contractor's versatility in fulfilling federal medical supply needs across multiple therapeutic domains, with the DLA Medical Supply Chain relying on this vendor as a critical source for pharmaceutical distribution to military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FQV2A?
SPE2DR26FQV2A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FQV2A worth?
The government has obligated $170,163 on SPE2DR26FQV2A.
Is contract SPE2DR26FQV2A an order under another contract?
Yes. SPE2DR26FQV2A is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV2A competed?
The extent of competition for SPE2DR26FQV2A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award